Consistent with the one previous initial report of ALG5 variants,6 affected individuals showed nonenlarged polycystic kidneys, tubulointerstitial atrophy and fibrosis, and slowly progressive CKD. This evidence concerns the gene ALG5 and chronic kidney disease.